Some reps are creating confusion over the risk of myopathy with Zocor (simvastatin) and other statins
August 2002
Some reps are creating confusion over the risk of myopathy with Zocor (simvastatin) and other statins.
This stems from changes in the U.S. labelling for Zocor, which now contains more info about the risk of myopathy and rhabdomyolysis.
For example, the new labelling says not to exceed 20 mg/day of Zocor in patients taking amiodarone or verapamil.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote